ClinConnect ClinConnect Logo
Search / Trial NCT06923683

Treatment for Social Cognition Disorders (T-ScEmo) in Patients With Acquired Brain Injury and Comorbid Neuropsychiatric Problems

Launched by GGZ OOST BRABANT · Apr 4, 2025

Trial Information

Current as of July 23, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • All patients:
  • have an established and documented history of ABI and current neuropsychiatric problems. When patients are referred to our institution, a team of clinical neuropsychologists, psychiatrists, and a high-educated nurse estimate whether patients meet these criteria by using a transdiagnostic tool.
  • have social cognition problems. These impairments in social cognition are established by defective scores on the Facial Expression of Emotion-Stimuli and Tests (FEEST) and/or (if available) frontal lesions visible on computed tomographic scan/magnetic resonance image, indicating higher risk on social behavioral problems. The FEEST is already used in standard care.
  • are at least 6 months post-injury to avoid the effects of spontaneous recovery.
  • are between 18 and 70 years.
  • have a significant other/proxy to fill in questionnaires and participate in the treatment. A life partner (persons living together in an intimate relationship, either married or unmarried) is preferred. When patients don't have a life partner, they are asked to bring an adult proxy (a close friend or family member) with whom they have frequent contact in daily life, preferably someone who already knew the patient from before the ABI.
  • Exclusion Criteria:
  • not being able to receive the T-ScEmo treatment, for example due to severe cognitive impairment
  • not speaking the Dutch language.

About Ggz Oost Brabant

Ggz Oost Brabant is a leading mental health care organization in the Netherlands, dedicated to providing comprehensive psychiatric services and innovative treatment solutions. With a strong commitment to research and development, Ggz Oost Brabant actively engages in clinical trials aimed at advancing mental health care practices and improving patient outcomes. The organization collaborates with various stakeholders, including academic institutions and healthcare professionals, to explore new therapeutic approaches and enhance the understanding of mental health disorders. Through its participation in clinical research, Ggz Oost Brabant strives to contribute to the body of knowledge in psychiatry while ensuring the highest standards of care for its patients.

Locations

Boekel, Noord Brabant, Netherlands

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported